ALPHA-9 THERANOSTICS Trademark

Trademark Overview

On Thursday, October 15, 2020, a trademark application was filed for ALPHA-9 THERANOSTICS with the United States Patent and Trademark Office. The USPTO has given the ALPHA-9 THERANOSTICS trademark a serial number of 90256438. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, June 28, 2024. This trademark is owned by Alpha-9 Theranostics Inc.. The ALPHA-9 THERANOSTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations, for the diagnosis and treatment of cancer

Development of medical products in the field of nuclear medicine
alpha-9 theranostics

General Information

Serial Number90256438
Word MarkALPHA-9 THERANOSTICS
Filing DateThursday, October 15, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations, for the diagnosis and treatment of cancer
Pseudo MarkALPHA-NINE THERANOSTICS
NOT AVAILABLE"THERANOSTICS"
Goods and ServicesDevelopment of medical products in the field of nuclear medicine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALPHA-9 ONCOLOGY INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressVANCOUVER V5T1M4
CA
Party NameAlpha-9 Theranostics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V7X1L3
CA

Trademark Events

Event DateEvent Description
Monday, October 19, 2020NEW APPLICATION ENTERED
Wednesday, December 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 11, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, March 16, 2021ASSIGNED TO EXAMINER
Thursday, March 18, 2021NON-FINAL ACTION WRITTEN
Thursday, March 18, 2021NON-FINAL ACTION E-MAILED
Thursday, March 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 8, 2021SUSPENSION LETTER WRITTEN
Wednesday, September 8, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, September 8, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 20, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, September 20, 2021EXAMINERS AMENDMENT E-MAILED
Monday, September 20, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 20, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, May 4, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 4, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, May 4, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, May 4, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, October 5, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 22, 2022ASSIGNED TO LIE
Tuesday, November 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 9, 2022SUSPENSION LETTER WRITTEN
Friday, December 9, 2022LETTER OF SUSPENSION E-MAILED
Friday, December 9, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 28, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 28, 2023SUSPENSION INQUIRY WRITTEN
Wednesday, June 28, 2023INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 20, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2023SUSPENSION LETTER WRITTEN
Wednesday, October 11, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, October 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 12, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, April 14, 2024SUSPENSION INQUIRY WRITTEN
Sunday, April 14, 2024INQUIRY TO SUSPENSION E-MAILED
Sunday, April 14, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, June 10, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, June 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 28, 2024SUSPENSION LETTER WRITTEN
Friday, June 28, 2024LETTER OF SUSPENSION E-MAILED
Friday, June 28, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

theranostics alpha preparations products medical field nuclear medicine development treatment radiotherapeutic namely